CAS 41354-03-4

1H-Indazole-3-carboxylicacid, 1-(phenylmethyl)-

Description:

1H-Indazole-3-carboxylic acid, 1-(phenylmethyl)-, with the CAS number 41354-03-4, is a chemical compound that features an indazole ring structure, which is a five-membered heterocyclic compound containing two nitrogen atoms. This substance is characterized by the presence of a carboxylic acid functional group (-COOH) at the 3-position of the indazole ring and a phenylmethyl group (benzyl group) at the 1-position. The compound is typically a solid at room temperature and may exhibit moderate solubility in polar solvents due to the carboxylic acid group. Its structure suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals, as indazole derivatives are known for various biological activities. The presence of both the indazole and the phenylmethyl moiety may influence its reactivity and interaction with biological targets. As with many organic compounds, proper handling and safety precautions should be observed due to potential toxicity or reactivity.

Formula: C₁₅H₁₂N₂O₂

Synonyms:

• 1-Benzyl-1H-indazole-3-carboxylicacid
• 1-Benzyl-3-indazolecarboxylic acid
• 1-Phenylmethyl-1H-indazole-3-carboxylic acid
• Af 1311Ts
• 1-Benzyl-1H-indazole-3-carboxylic acid

1H-​Indazole-​3-​carboxylic acid, 1-​(phenylmethyl)​-

CAS: 41354-03-4

Formula: C₁₅H₁₂N₂O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 252.2680

Ref: IN-DA00I836

1-Benzyl-1H-Indazole-3-Carboxylic Acid

CAS: 41354-03-4

1-Benzyl-1H-Indazole-3-Carboxylic Acid

Purity: 98%

Molecular weight: 252.27g/mol

Ref: 54-OR1029374

1-Benzyl-1H-indazole-3-carboxylic acid

CAS: 41354-03-4

Purity: 95.0%

Color and Shape: Solid

Molecular weight: 252.2729949951172

Ref: 10-F061049

1-Benzyl-1H-indazole-3-carbonic acid

Controlled Product

CAS: 41354-03-4

1-Benzyl-1H-indazole-3-carbonic acid (1BZICA) is a new cannabinoid receptor agonist that has been shown to have an affinity for the CB1 and CB2 cannabinoid receptors in the nanomolar range. 1BZICA is hydrophobic and binds to these receptors with high affinity and selectivity, which makes it a potential therapeutic candidate for the treatment of pain, inflammation, and other conditions. The drug has been shown to be effective in animal assays at doses as low as 10 mg/kg. 1BZICA has also been shown to be a potent inhibitor of endocannabinoid deactivation by inhibiting carboxylesterase activity. This may lead to enhanced therapeutic effects for disorders such as chronic pain or inflammation.

Formula: C₁₅H₁₂N₂O₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 252.27 g/mol

Ref: 3D-FB67563